Effect of different chemotherapy schemes on early-stage breast cancer patients with Low HER-2 expression.

Xu, Yurui; Chao, Lin; Wang, Jianyu; Sun, Yonghong; Li, Chen

Xu, Yurui; Chao, Lin; Wang, Jianyu; Sun, Yonghong; Li, Chen.

Afiliación

Xu Y; Yurui Xu, Department of Breast and Thyroid, Wuxi No.2 People's, Hospital Affiliated Nanjing Medical University, Wuxi 214002, Jiangsu, China.
Chao L; Lin Chao, Department of Breast and Thyroid, Wuxi No.2 People's, Hospital Affiliated Nanjing Medical University, Wuxi 214002, Jiangsu, China.
Wang J; Jianyu Wang, Department of Breast and Thyroid, Wuxi No.2 People's, Hospital Affiliated Nanjing Medical University, Wuxi 214002, Jiangsu, China.
Sun Y; Yonghong Sun, Department of Breast and Thyroid, Wuxi No.2 People's, Hospital Affiliated Nanjing Medical University, Wuxi 214002, Jiangsu, China.
Li C; Chen Li, Department of Breast and Thyroid, Wuxi No.2 People's, Hospital Affiliated Nanjing Medical University, Wuxi 214002, Jiangsu, China.

Pak J Med Sci ; 39(5): 1355-1360, 2023.

Article en En | MEDLINE | ID: mdl-37680804

Palabras clave

Adjuvant chemotherapy; Breast cancer; Liposome-encapsulated doxorubicin; Low HER2 expression

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pak J Med Sci Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Pakistán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google